QuantumSi is trading 10.34% up at $1.18 in pre-market on October 1 after interim results showed Proteus outperforming Platinum Pro across reported measures. - Control study: 30 times more alignments; all 24 panel proteins detected, versus 20.3 on average with Platinum Pro. - Results are preliminary; Proteus, consumables and software remain in development and are not fully optimized. - Shares rose September 29 and 30, continuing a sharp recent run; September 30 close: $1.07.